International Society of Addiction Medicine Annual Conference

摘要 国际成瘾医学学会（ISAM）致力于提供支持性的学术 国际成瘾医学领域成员的网络。我们通过电子 交流，就与该领域有关的问题编写协商一致的立场文件， 与吸毒成瘾和包括艾滋病毒等感染在内的相关并发症有关的领域， 召开会议，由世界各地的同事传播关于该领域进展的信息， 为来自资源相对较少国家的从业人员提供机会， 参与/出席。我们还建立了一个成瘾问题国际认证程序 药因此，ISAM自1999年以来一直致力于促进全世界更好地了解， 成瘾医学领域的医生和专职医疗人员， 虐待、心理/精神后果和疾病过程，包括艾滋病毒和其他血液- 传播的病原体。这一合作的一个重要成果是认识到， 药物滥用中的“全球”因素，与医疗/精神病学/社会后果相关，无论 种族、性别、文化或民族。我们在一个国家组织/出席会议， 来自世界各地的临床医生将有助于当地的临床成瘾医学专家在设置 提供必要的戒毒/临床医学服务。我们的目标，建立一个强大的，团结的，知情的 与其他学科合作，代表患者在预防和 全球成瘾管理，得到了我们年度会议的大力支持， 国家卫生研究院/国家国际开发署会议赠款提供的财政和咨询援助（2006年; 2007-2010年; 2011-2015年）。 正在通过这一延期申请寻求资金，以支持将于2016-2020年举行的年度会议 在不同的国家目前，2014年日本横滨会议刚刚结束。场馆 随后的年度会议将在邓迪，苏格兰，英国（2015年），里约热内卢 巴西里约热内卢（2016年）、阿联酋阿布扎比（2017年）和韩国釜山（2018年）。（2019-20场比赛将在 确定，但暂定将在伊兹密尔，土耳其，2019年，无论是在北京，中国或在班加罗尔， 印度2020年）。 虽然该组织和我们的会议在NIDA的帮助下取得了重大进展，但我们计划 保留未来会议的独特元素，这将有助于树立“特色”。其中包括：1） 综合学术/娱乐服务，2）公开讨论/交流的正式机会 总结计划会议，3）包括会议计划内容，以介绍新的/新兴的 成瘾和相关发病率的科学，包括艾滋病毒、丙型肝炎病毒和其他感染，4） 有系统地改变会议的全球地理地点， 5）致力于支持/指导年轻人/经济状况不佳的大学发展， 全球成瘾医学界的资源丰富的成员。本组织受益于 这不仅得益于上届会议提供的财政和咨询支持， 赠款，但重要的专业知识，时间，并认为许多成员的NIDA执行人员 他们接受邀请在过去的会议上发言，这使我们感到荣幸。我们期待着继续 这种联系为我们的工作提供了最有意义的补充， 激励年轻的科学家/成瘾医学从业者，本组织希望为他们提供 提供一个良师益友和同事共事的氛围。因此，继续提供这种支持是非常重要的。 ISAM作为一个组织的优先事项。 主要研究者联系人： 博士Gregory C.短打 高级副总裁/医务 Daytop Village，Inc. 西40街54号，5楼 纽约州纽约10018 电话：（212）354-6000，ext. 220 传真：（212）391-9265 电子邮件地址：gbunt@daytop.org ISAM总部联系方式 博士纳迪·盖巴利 ISAM首席审查员 FMC戒毒中心 1403 - 29 Street NW Calgary AB T2N 2T9 电话：（403）944-2025 传真：（403）944-2056 电子邮件：nady. calgaryhealthregion.ca

Abstract The International Society of Addiction Medicine (ISAM) is dedicated to providing a supportive academic network to members of the international addiction medicine field. We accomplish this via electronic communication, development of consensual position papers on issues relevant to the field, research in all areas relating to drug addiction and associated co-morbidity including infections such as HIV, and annual conferences to disseminate information on advances in the field by colleagues worldwide, with a priority on providing opportunities for practitioners from countries with relatively few resources to participate/present. We have also established a process of International Certification in Addiction Medicine. ISAM has thus been working since 1999 to promote better understanding worldwide, among physicians and allied health professionals in the field of addiction medicine, of connections among drug abuse, psychological/psychiatric consequences, and disease processes including HIV and other blood- borne pathogens. One significant outcome of this collaboration has been the recognition that there are “global” factors in substance abuse, associated with medical/psychiatric/social consequences regardless of race, gender, culture, or ethnicity. We organize/present conferences in a country where the assistance from clinicians from around the world would help the local clinical addiction medicine experts in setting up the necessary addiction/clinical medicine services. Our goal, to build a strong, united, informed medical voice in collaboration with other disciplines to speak on behalf of patients in prevention and management of addictions worldwide, has been significantly supported by our annual conferences with fiscal and advisory assistance provided by NIH/NIDA Conference Grants (2006; 2007-2010; 2011-2015). Funds are being sought through this renewal application to support annual meetings 2016-2020 to be held in different countries. Currently the Yokohama, Japan, 2014 conference has just concluded. The venues for the subsequent Annual Conferences will be in Dundee, Scotland, United Kingdom (2015), Rio de Janeiro, Brazil (2016), Abu Dhabi, UAE (2017) and Busan, Korea (2018). (2019-20 venues are to be determined, but tentatively will be in Izmir, Turkey, 2019, and either in Beijing, China or in Bangalore, India 2020). While the organization and our conference have evolved significantly with NIDA’s assistance, we plan to retain unique elements of the future conferences that will help set “characters.” Those include: 1) integrated academic/recreational offerings, 2) formalized opportunities for open discussion/exchange concluding program sessions, 3) inclusion of conference program content to present new/emerging science of addiction and associated morbidity including infections such as HIV, HCV and others,4) systematically varying global geographic sites of conferences, promoting local attendance/regional access, and 5) dedication to support/mentorship for collegial development of young/economically under- resourced members of the worldwide addiction medicine community. The organization has benefited significantly from not only the financial and consultative support afforded by the previous conference grant, but by the significant expertise, time, and thought of many members of the NIDA executive staff who have honored us by accepting invitations to speak at past meetings. We look forward to continuing that association, which has provided most meaningful additions to our proceedings as well as important inspiration to younger scientists/addiction medicine practitioners for whom the organization desires to provide an atmosphere of mentorship and collegiality. Thus continuing such support is of very high priority to ISAM as an organization. Principal Investigator Contact: Dr. Gregory C. Bunt Senior Vice-President/Medical Daytop Village, Inc. 54 West 40th St., 5th Floor New York, N.Y. 10018 Tel: (212) 354-6000, ext. 220 Fax: (212) 391-9265 Email: gbunt@daytop.org ISAM Head Office Contact Dr. Nady el-Guebaly Chief Examiner, ISAM FMC Addiction Centre 1403 – 29 Street NW Calgary AB T2N 2T9 Tel: (403) 944-2025 Fax: (403) 944-2056 Email: nady.el-guebaly@calgaryhealthregion.ca